CN103364567B - A kind of surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof - Google Patents
A kind of surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof Download PDFInfo
- Publication number
- CN103364567B CN103364567B CN201310303103.0A CN201310303103A CN103364567B CN 103364567 B CN103364567 B CN 103364567B CN 201310303103 A CN201310303103 A CN 201310303103A CN 103364567 B CN103364567 B CN 103364567B
- Authority
- CN
- China
- Prior art keywords
- liquid
- preparation
- surfactant
- antibody
- surfactant proteind
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 48
- 238000001514 detection method Methods 0.000 title claims abstract description 10
- 239000006249 magnetic particle Substances 0.000 title claims description 12
- 108010007127 Pulmonary Surfactant-Associated Protein D Proteins 0.000 title claims description 3
- 102100027845 Pulmonary surfactant-associated protein D Human genes 0.000 title claims description 3
- 230000036039 immunity Effects 0.000 title claims description 3
- 239000004094 surface-active agent Substances 0.000 claims abstract description 62
- 239000007788 liquid Substances 0.000 claims abstract description 50
- 238000003908 quality control method Methods 0.000 claims abstract description 32
- 238000006243 chemical reaction Methods 0.000 claims abstract description 26
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims abstract description 22
- 238000005406 washing Methods 0.000 claims abstract description 22
- 108090000790 Enzymes Proteins 0.000 claims abstract description 17
- 102000004190 Enzymes Human genes 0.000 claims abstract description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 16
- 239000006210 lotion Substances 0.000 claims abstract description 16
- 235000020958 biotin Nutrition 0.000 claims abstract description 12
- 230000008878 coupling Effects 0.000 claims abstract description 12
- 238000010168 coupling process Methods 0.000 claims abstract description 12
- 238000005859 coupling reaction Methods 0.000 claims abstract description 12
- 229960002685 biotin Drugs 0.000 claims abstract description 11
- 239000011616 biotin Substances 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 10
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims abstract description 9
- 108010090804 Streptavidin Proteins 0.000 claims abstract description 6
- 238000004020 luminiscence type Methods 0.000 claims abstract description 6
- 230000000694 effects Effects 0.000 claims abstract description 4
- 239000011859 microparticle Substances 0.000 claims abstract description 4
- 239000000047 product Substances 0.000 claims description 40
- 239000000243 solution Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 25
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 24
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 15
- 239000011553 magnetic fluid Substances 0.000 claims description 15
- 239000012153 distilled water Substances 0.000 claims description 14
- 238000013016 damping Methods 0.000 claims description 13
- 239000012895 dilution Substances 0.000 claims description 12
- 238000010790 dilution Methods 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 8
- 230000035945 sensitivity Effects 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 6
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- VSMDINRNYYEDRN-UHFFFAOYSA-N 4-iodophenol Chemical compound OC1=CC=C(I)C=C1 VSMDINRNYYEDRN-UHFFFAOYSA-N 0.000 claims description 5
- 238000000502 dialysis Methods 0.000 claims description 5
- 231100000673 dose–response relationship Toxicity 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 5
- -1 polyethylene Polymers 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004342 Benzoyl peroxide Substances 0.000 claims description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002594 Polyethylene Glycol 8000 Polymers 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 241000220317 Rosa Species 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 3
- 235000019270 ammonium chloride Nutrition 0.000 claims description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 claims description 3
- 238000007334 copolymerization reaction Methods 0.000 claims description 3
- 238000004132 cross linking Methods 0.000 claims description 3
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 3
- 235000019800 disodium phosphate Nutrition 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 3
- 150000002505 iron Chemical class 0.000 claims description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 3
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 239000012266 salt solution Substances 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- RDEIXVOBVLKYNT-HDZPSJEVSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-[(1r)-1-aminoethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2 Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)[C@@H](C)N)N)[C@@H](N)C[C@H]1N.O1[C@H]([C@@H](C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-HDZPSJEVSA-N 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 229910052742 iron Inorganic materials 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims 1
- 150000001615 biotins Chemical class 0.000 claims 1
- 235000012730 carminic acid Nutrition 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 abstract description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 238000012360 testing method Methods 0.000 description 6
- 208000029523 Interstitial Lung disease Diseases 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000428 dust Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 108010007100 Pulmonary Surfactant-Associated Protein A Proteins 0.000 description 2
- 108010007131 Pulmonary Surfactant-Associated Protein B Proteins 0.000 description 2
- 108010007125 Pulmonary Surfactant-Associated Protein C Proteins 0.000 description 2
- 102000007620 Pulmonary Surfactant-Associated Protein C Human genes 0.000 description 2
- 102100027773 Pulmonary surfactant-associated protein A2 Human genes 0.000 description 2
- 102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000001574 biopsy Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 229940127121 immunoconjugate Drugs 0.000 description 2
- 239000003580 lung surfactant Substances 0.000 description 2
- 239000006148 magnetic separator Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241000872931 Myoporum sandwicense Species 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 210000001132 alveolar macrophage Anatomy 0.000 description 1
- 210000002588 alveolar type II cell Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 208000010749 gastric carcinoma Diseases 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 238000001814 protein method Methods 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 201000000498 stomach carcinoma Diseases 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention discloses a kind of Surfactant proteinD (SP-D) nano magnetic particulate chemistry electrochemiluminescent immunoassay immue quantitative detection reagent box, described kit comprises: Surfactant proteinD calibration object; Coupling has the nano magnetic microparticle suspending liquid of Streptavidin; Biotin labeled Surfactant proteinD antibody; Surfactant proteinD abzyme bond, enzyme used is horseradish peroxidase, horseradish peroxidase purity RZ >=3.0, activity >=250U/mL; Surfactant proteinD quality-control product; Chemical luminescence for liquid A liquid and B liquid; 20 times of concentrated washing lotions; Reaction tube.The invention also discloses the preparation method of kit of the present invention in addition.Kit of the present invention is highly sensitive compared with available reagent box, can measure that concentration range is wide, the reagent term of validity is long, reagent cost is low, simple to operate, detect automaticity advantages of higher.
Description
Technical field
The present invention relates to field of immunoassay medicine, concrete, the invention provides a kind of Surfactant proteinD (SP-D) nano magnetic particulate chemistry electrochemiluminescent immunoassay immue quantitative detection reagent box and preparation method thereof.
Background technology
Pulmonary surfactant (pulmonary surfactant, PS) be synthesized by alveolar type II cells and secrete a kind of lipoprotein of complexity, the one be made up of phosphatide and protein has surface-active compound, wherein 90% is phosphatide, 8%-9% is surfactant protein (Surfactant protein, SP), SP mainly comprises SP-A, SP-B, SP-C, SP-D, wherein SP-B and SP-C is hydrophobic small molecules albumen, SP-A and SP-D is large hydrophilic molecular albumen, the above two can reduce alveolar surface tension, and rear both then mainly regulate lung immunologic function.First SP-D finds in respiratory system, the glycoprotein of to be a kind of molecular weight be 43KD, research shows that SP-D can strengthen the resistivity of respiratory tract as immunologic active material, defend the invasion and attack of microorganism and dust, not only can directly be combined with silicious dust specifically, and the phagocytosis of pulmonary macrophage to silicious dust can also be strengthened, after silicious dust enters lung tissue, the expression of lung tissue SP-D can increase.
Interstitial lung disease (ILD) a kind ofly has the inflammation of multi-form and degree and fiber with alveolus wall and alveolar space and turn to characteristic pathological and change, the general name of the Diffuse-type gastric carcinoma being main clinical manifestation in the infiltration shadow extensively distributed with Progressive symmetric erythrokeratodermia expiratory dyspnea and x-ray rabat.Current judgement ILD mainly relies on the means such as imaging examination, biopsy, routine blood test, enzyme linked immunological Serologic detection, research show 10% the inspection of ILD patient's x-ray normal, but proved by pathology is ILD, now patient's serum SP-D level when x-ray can not detect significantly raises; Biopsy also may cause undetected due to got pathology location difference.
Enzymoimmunoassay possesses simple to operate, cheap, precision is high, specificity is good, accuracy is good, be a kind of minimal feeding technology preferably, but susceptibility is relatively low, between plate, difference is large, measured value repeatability is poor, and mark enzyme-to-substrate used can quantitative measurement narrow range, and the shortcoming such as Instrument measuring narrow range.
Chemiluminescent immunoassay(CLIA) research is started in the beginning of the eighties, and fast development is applied to the nineties, is current microimmuno-assays the most responsive.
Summary of the invention
The problem to be solved in the present invention chemiluminescence immunoassay immue quantitative detection reagent box being to provide surfactant protein and preparation method thereof, avoids measured value poor repeatability, the defects such as euzymelinked immunosorbent assay (ELISA) sensitivity is low, and sensing range is narrow.
For solving the problems of the technologies described above, the technical solution used in the present invention is: Surfactant proteinD (SP-D) nano magnetic particulate chemistry electrochemiluminescent immunoassay immue quantitative detection reagent box, comprising: Surfactant proteinD calibration object; Coupling has the nano magnetic microparticle suspending liquid of Streptavidin; Biotin labeled Surfactant proteinD antibody; Surfactant proteinD abzyme bond, enzyme used is horseradish peroxidase, horseradish peroxidase purity RZ >=3.0, activity >=250U/mL; Surfactant proteinD quality-control product, quality-control product comprises the low value quality-control product of concentration 3ng/mL and the high level quality-control product of 600ng/mL; Chemical luminescence for liquid A liquid and B liquid, A liquid is the Tris-HCl damping fluid of 5mmol/L, pH8.6, and containing final concentration 0.7g/L luminol and final concentration 0.165g/L p-iodophenol in this damping fluid; B liquid is 0.675g/L urea peroxide; 20 times of concentrated washing lotions; Reaction tube.
Further, described nano magnetic particulate is the tri-iron tetroxide that surface wraps up with amino or carboxyl-reactive group, particle diameter 10-50nm.
Further, the material of described reaction tube is transparent polystyrene, tygon, polypropylene or glass.
The preparation method of kit, comprises the following steps:
(1) preparation of Surfactant proteinD calibration object:
By Surfactant proteinD sterling calibration object diluted to each concentration point position 0,2,10,50,200,1000ng/mL;
Described calibration object dilution is the damping fluid containing 30% cow's serum;
(2) preparation of Surfactant proteinD quality-control product:
With calibration object dilution, Surfactant proteinD sterling is diluted to 3ng/mL and 600ng/mL, 3ng/mL is as low value quality-control product, and 600ng/mL is as high level quality-control product;
(3) preparation of nano magnetic particulate-Streptavidin suspending liquid:
Prepared by A, ferriferrous oxide nano magnetic particle
Adopt the precipitation method to prepare ferriferrous oxide nano magnetic particle, concrete preparation method is as follows: 1) by FeCl
36H
2o and FeCl
24H
2o joins in distilled water with mol ratio 2:1, dissolved with vigorous agitation; 2) add 0.5M ammoniacal liquor under nitrogen atmosphere in above-mentioned iron salt solutions, adjust pH9-10, temperature of reaction 65 DEG C, reaction time 45min; 3), after reaction terminates, be washed with distilled water to neutrality, abandon supernatant, in 60 DEG C of oven dry, obtain the ferriferrous oxide nano magnetic particle of 10-50nm;
The coupling of B, nanometer magnetic bead surface carboxyl groups
Dispersion copolymerization method is adopted to carry out coupling, concrete preparation method is as follows: the nano magnetic microparticulate ultrasound getting above-mentioned preparation is dispersed in 10%PEG8000 solution, obtain magnetic fluid solution, in magnetic fluid solution, 1:10 adds absolute ethyl alcohol by volume, after stirring 30min, moves into stirrer, condenser pipe, in the three-necked bottle of nitrogen inlet, add crosslinking chemical N, N '-methylene-bisacrylamide; Under the protection of nitrogen, be warming up to 60 ± 1 DEG C, constant temperature stirs 30min, add the benzoyl peroxide of magnetic fluid volume 3% afterwards successively, stirring rate is about 500rpm, the styrene of magnetic fluid solution same volume, the acrylic acid of magnetic fluid liquor capacity 25%, keep stream of nitrogen gas, all the other conditions remain unchanged, reaction 8-10h, products therefrom leaves standstill, and uses distilled water cyclic washing, then regulates pH=1 with hydrochloric acid, soak 24h, leave standstill; Use distilled water cyclic washing again, remove not coated Fe
3o
4magnetic, puts into dry 24h at vacuum drying chamber 50 DEG C the product precipitated, obtains the nano magnetic particulate that surface is associated with carboxyl;
The preparation of C, nano magnetic particulate-Streptavidin suspending liquid, preparation 1L, method is as follows:
Get 100mL0.1M MES damping fluid, add the nano magnetic particulate that 10mg surface is associated with carboxyl, stirring at room temperature 40min, add 3.5mg Streptavidin afterwards, then 8mg/mLEDC solution is added, after 2-8 DEG C of reaction 1h, with 0.01M PBS buffer solution 3 times, be finally dissolved to 1L with 0.01M PBS;
(4) preparation of biotin labeled Surfactant proteinD antibody
The preparation of A, Surfactant proteinD antibody
Conveniently immunization method prepares Surfactant proteinD antibody.
The preparation of B, biotin labeled Surfactant proteinD antibody
Get 0.8mg Surfactant proteinD antibody, to dialyse at 2 ~ 8 DEG C 1 ~ 3h with borate buffer solution; Antibody after dialysis is added 65ug biotin, adds dimethyl sulfoxide (DMSO) simultaneously, make dimethyl sulfoxide (DMSO) final mass concentration be greater than 5%, slowly vibrate, lucifuge reaction 2.5h; 250uL1M ammonium chloride solution is added, reacting at normal temperature without light 30-60min in above-mentioned solution; To dialyse at 2 ~ 8 DEG C 24h by 0.01M PBS solution, period changes liquid 2-4 time;
(5) preparation of Surfactant proteinD abzyme bond
After adopting improvement sodium periodate oxidation that Surfactant proteinD antibody and horseradish peroxidase are carried out coupling, be diluted to working concentration 1:4500 with enzyme dilution, and added 11% enzyme stabilizers, be stored in 2 ~ 8 DEG C;
The preparation of (6) 20 times of concentrated washing lotions
20 times of concentrated washing lotions comprise 58g/L sodium hydrogen phosphate, 5.92g/L sodium dihydrogen phosphate, 180g/L NaCl, 10mL/LTween-20 and 2%Proclin300;
(7) preparation of chemical luminescence for liquid A liquid and B liquid
A liquid is 0.7g/L luminol, 0.165g/L p-iodophenol, and damping fluid is the 5mmol/L Tris-HCl of pH8.6, keeps in Dark Place; B liquid is 0.675g/L urea peroxide, prepares with process water; The 5min mixing before use of A liquid and B liquid;
(8) assemble: mentioned reagent is assembled into box, is stored in 2 ~ 8 DEG C, each one bottle of often kind of reagent;
(9) to adopting the kit prepared of the method to carry out physical examination, the measured value of linear, precision, the specificity of accuracy, dose-response curve, sensitivity, quality-control product and stability are measured.
Principle of the present invention is, adopt the SP-D in double antibody sandwich method mensuration serum or blood plasma, biotin-SP-D antibody conjugates is added in Avidin-nano magnetic microparticle suspending liquid, by the compatible reaction of Avidin and biotin, form magnetic particle-Avidin-Biotin-SP-D antibody complex, add sample and enzyme, pass through antigen-antibody reaction, form magnetic particle-Avidin-Biotin-SP-D antibody-SP-D antigen-SP-D antibody-HRP compound, with magnetic field, compound is adsorbed on bottom test tube, wash free composition, add substrate working fluid, under oxygenant effect, HRP catalysis luminol generates the aminophthalic acid ion being in excited state, when it returns to ground state, discharge the photon of 425nm, the luminous value RLU of each well is measured in the 5th minute.RLU and the sample SP-D concentration of sample are proportionate.SP-D concentration in sample is according to the Log(X set up by calibration object SP-D concentration and corresponding RLU)-Log(Y) mathematical model is carried out quantitatively, thus the SP-D content in detection human serum, blood plasma.
The Surfactant proteinD nano magnetic particulate chemistry electrochemiluminescent immunoassay quantitative determination reagent kit of invention, has the following advantages:
(1) highly sensitive, the sensitivity for analysis of this kit is not higher than 0.8ng/mL.
(2) accuracy is good, and in batch, imprecision is not higher than 5%, and between batch, imprecision is not higher than 10%.
(3) cost is low, and compare with like product on market, this kit is functional, and cost is low, has clinical value.
(4) have good stability, this product can deposit more than 7 days at 37 DEG C, can deposit 1 year at 2 ~ 8 DEG C.
Accompanying drawing explanation
Fig. 1 is the measurement result comparison diagram of kit measurement Surfactant proteinD of the present invention and Enzyme immunoassay Surfactant proteinD, wherein ordinate is the Surfactant proteinD value that this kit records, horizontal ordinate is that enzyme exempts from kit mensuration Surfactant proteinD value, two kinds of method correlation coefficient r=0.9839, straight-line equation y=0.9657x+0.1997.
Fig. 2 is the preparation technology of Surfactant proteinD antibody
Embodiment
Embodiment 1: prepare Surfactant proteinD nano magnetic particulate chemistry electrochemiluminescent immunoassay quantitative determination reagent kit
(1) preparation of Surfactant proteinD calibration object:
By Surfactant proteinD sterling (purchased from US BIO company) calibration object diluted extremely each concentration point position 0,2,10,50,200,1000ng/mL;
Described calibration object dilution is the damping fluid containing 30% cow's serum;
(2) preparation of Surfactant proteinD quality-control product:
With calibration object dilution, Surfactant proteinD sterling is diluted to 3ng/mL and 600ng/mL, 3ng/mL is as low value quality-control product, and 600ng/mL is as high level quality-control product;
(3) preparation of nano magnetic particulate-Streptavidin suspending liquid:
Prepared by A, ferriferrous oxide nano magnetic particle
Adopt the precipitation method to prepare ferriferrous oxide nano magnetic particle, concrete preparation method is as follows: 1) by FeCl
36H
2o and FeCl
24H
2o joins in distilled water with mol ratio 2:1, dissolved with vigorous agitation; 2) add 0.5M ammoniacal liquor under nitrogen atmosphere in above-mentioned iron salt solutions, adjust pH9-10, temperature of reaction 65 DEG C, reaction time 45min; 3), after reaction terminates, be washed with distilled water to neutrality, abandon supernatant, in 60 DEG C of oven dry, obtain the ferriferrous oxide nano magnetic particle of 10-50nm;
The coupling of B, nanometer magnetic bead surface carboxyl groups
Dispersion copolymerization method is adopted to carry out coupling, concrete preparation method is as follows: the nano magnetic microparticulate ultrasound getting above-mentioned preparation is dispersed in 10%PEG8000 solution, obtain magnetic fluid solution, in magnetic fluid solution, 1:10 adds absolute ethyl alcohol by volume, after stirring 30min, moves into stirrer, condenser pipe, in the three-necked bottle of nitrogen inlet, add crosslinking chemical N, N '-methylene-bisacrylamide; Under the protection of nitrogen, be warming up to 60 ± 1 DEG C, constant temperature stirs 30min, add the benzoyl peroxide of magnetic fluid volume 3% afterwards successively, stirring rate is about 500rpm, the styrene of magnetic fluid solution same volume, the acrylic acid of magnetic fluid liquor capacity 25%, keep stream of nitrogen gas, all the other conditions remain unchanged, reaction 8-10h, products therefrom leaves standstill, and uses distilled water cyclic washing, then regulates pH=1 with hydrochloric acid, soak 24h, leave standstill; Use distilled water cyclic washing again, remove not coated Fe
3o
4magnetic, puts into dry 24h at vacuum drying chamber 50 DEG C the product precipitated, obtains the nano magnetic particulate that surface is associated with carboxyl;
The preparation of C, nano magnetic particulate-Streptavidin suspending liquid, preparation 1L, method is as follows:
Get 100mL0.1M MES damping fluid, add the nano magnetic particulate that 10mg surface is associated with carboxyl, stirring at room temperature 40min, add 3.5mg Streptavidin afterwards, then 8mg/mLEDC solution is added, after 2-8 DEG C of reaction 1h, with 0.01M PBS buffer solution 3 times, be finally dissolved to 1L with 0.01M PBS;
(4) preparation of biotin labeled Surfactant proteinD antibody
The preparation of A, Surfactant proteinD antibody
Surfactant proteinD antibody is prepared according to the technological process of Fig. 2.
The preparation of B, biotin labeled Surfactant proteinD antibody
Get 0.8mg Surfactant proteinD antibody, to dialyse at 2 ~ 8 DEG C 1 ~ 3h with borate buffer solution; Antibody after dialysis is added 65ug biotin, adds dimethyl sulfoxide (DMSO) simultaneously, make dimethyl sulfoxide (DMSO) final mass concentration be greater than 5%, slowly vibrate, lucifuge reaction 2.5h; 250uL1M ammonium chloride solution is added, reacting at normal temperature without light 30-60min in above-mentioned solution; To dialyse at 2 ~ 8 DEG C 24h by 0.01M PBS solution, period changes liquid 2-4 time;
(5) preparation of Surfactant proteinD abzyme bond
After adopting improvement sodium periodate oxidation that Surfactant proteinD antibody and horseradish peroxidase are carried out coupling, be diluted to working concentration 1:4500 with enzyme dilution, and added 11% enzyme stabilizers, be stored in 2 ~ 8 DEG C;
Improvement sodium periodate oxidizing process step comprises:
A:HRP activates
1) 10mg/mL HRP solution is configured;
2) 12.8mg/mL sodium periodate NaIO is configured
4solution;
3) by the 1:1 mixing by volume of above-mentioned 1 and 2 obtain solutions, 4 DEG C of lucifuge reaction 30min;
4) configuration concentration is the glycol water of 20uL/mL, mixes, reacting at normal temperature without light 20min with above-mentioned solution 3 with same volume, and namely activation completes, and puts-20 DEG C of preservations (holding time is no more than 3 months).
B, SP-D labeling of monoclonal antibody
1) raw material to be marked is loaded in bag filter, with the carbonate buffer solution of 0.05M pH9.6, dialysis 30min;
2) by the HRP of mark raw material and activation in mass ratio 1:2 mix, during 4 DEG C are dialysed 24h(, change liquid 2-3 time with 0.05M carbonate buffer solution afterwards);
3) configuration concentration is the NaBH of 2mg/mL
4aqueous solution, adds by 1mgHRP the NaBH that 80uL prepares
4the ratio of aqueous solution mixes, and in 4 DEG C of lucifuge reaction 2h;
4) marking fluid 0.01M PBS above-mentioned steps 3 completed, in 4 DEG C of dialysis 24h, adds equal-volume glycerine ,-20 DEG C of preservations.
Enzyme dilution comprises 10mL/L2M NaOH, 15g/L NaCl, 10g/LBSA, 5g/L Dextran T-2000(available from Sigma), 1.05g/L Triton X-100(available from Sigma), 2.5mL/L gentamicin sulphate, (famille rose is powder solid to 1mL/L famille rose, be mixed with concentration 40mg/mL to use later), 2g/L Tween-20(available from Sigma), 1mL/L ProClin300(available from Sigma);
The preparation of (6) 20 times of concentrated washing lotions
20 times of concentrated washing lotions comprise 58g/L sodium hydrogen phosphate, 5.92g/L sodium dihydrogen phosphate, 180g/L NaCl, 10mL/LTween-20 and 2%Proclin300;
(7) preparation of chemical luminescence for liquid A liquid and B liquid
A liquid is 0.7g/L luminol, 0.165g/L p-iodophenol, and damping fluid is the 5mmol/L Tris-HCl of pH8.6, keeps in Dark Place; B liquid is 0.675g/L urea peroxide, prepares with process water; The 5min mixing before use of A liquid and B liquid;
(8) assemble: mentioned reagent is assembled into box, is stored in 2 ~ 8 DEG C, each one bottle of often kind of reagent;
(9) to adopting the kit prepared of the method to carry out physical examination, the measured value of linear, precision, the specificity of accuracy, dose-response curve, sensitivity, quality-control product and stability are measured.
Embodiment 2: the inspection of kit of the present invention
(1) physical examination: liquid component should be clarified, without precipitation or floccus; Other components should without packages in damaged condition.
(2) dose-response curve is linear: use double-log Model fitting, and dose-response curve correlation coefficient r absolute value in 0-1000ng/mL concentration range is not less than 0.9900.
(3) sensitivity for analysis: kit assay sensitivity is not higher than 0.8ng/mL.
(4) precision: 10 hole replicate determination high level and low value quality-control product, calculates the mean concentration of measurement result
with standard deviation (SD), imprecision in batch
Use 3 batches of products to carry out 3 tests, calculate the mean concentration of measurement result
with standard deviation (SD), imprecision between batch
result should meet batch interior imprecision (CV%) should not higher than 5%; Between batch, imprecision (CV%) should not higher than 10%.
(5) measured value of quality-control product: the quality-control product of replicate determination 10 hole high level and low value, with Log (X)-Log (Y) Model fitting, quality-control product measured value should in allowed band, low value quality-control product measured value is at 2.4-3.6ng/mL, and high level quality-control product measured value is at 480-720ng/mL.
(6) stability: place 7 days for 37 DEG C, measured value should meet above-mentioned requirements.
Embodiment 3: the using method of kit of the present invention
(1) kit to be checked is balanced 30 minutes under room temperature (18 ~ 25 DEG C).
(2) washing lotion is prepared: washing lotion will be concentrated by 1:20 dilution (1mL washing lotion adds 19mL distilled water) with distilled water.If concentrated washing lotion has crystallization, concentrated washing lotion can be placed in room temperature or 37 DEG C, dilute again after dissolving to be crystallized.
(3) luminescent solution is prepared: use first 5 minutes and get appropriate luminescent solution A and mix with luminescent solution B equal-volume.
(4) reaction tube is numbered, 25uL calibration object or serum specimen is added successively in test tube, 50uL magnetic-particle-Streptavidin suspending liquid, 50uL biotin-surfactant protein antibody conjugates, 100uL surfactant protein abzyme bond, oscillating reactions 30min at 37 DEG C, test tube rack is placed on magnetic separator and is separated 5min, then supernatant is poured out, add 500uL washing lotion, after abundant mixing, be separated on magnetic separator, pour out washing lotion, repeat 3 times, Chemoluminescent substrate 100uL is added in each pipe, abundant mixing, secretly put 5min, tube-type chemical light-emitting appearance measures the luminous value (RLU) of each pipe, with the Log value of calibration object concentration for horizontal ordinate, with the Log of luminous value for ordinate, drawing standard curve, the concentration of surfactant protein can be calculated according to the luminous value of serum specimen.
Embodiment 4: the evaluation of methodology result of this kit
Sensing range: scope is 0-1000ng/mL, measures after the sample being greater than 1000ng/mL for concentration should first dilute again.
Sensitivity: 0.8ng/mL.
Precision: be less than 5%.
Accuracy: the mean value of the recovery is in 0.90 ~ 1.10 scope.
Quality-control product measured value: the measured value of low value quality-control product QcL and high level quality-control product QcH is all in allowed band, and low value quality-control product measured value is at 2.4-3.6ng/mL, and high level quality-control product measured value is at 480-720ng/mL.
Stability: reagent component each in kit is placed 7d at 37 DEG C, has good stability.
Embodiment 5: the clinical comparison experiment of this kit
The kit of invention has carried out clinical examination, total sample number 280 example of this clinical testing, after first exempting from detection kit test with Surfactant proteinD enzyme, the kit of invention (chemiluminescence) is used to measure again, result shows, straight-line equation is y=0.9657x+0.1997, correlation coefficient r=0.9839.Kit prepared by visible this method and enzyme exempt from measured value good consistance.With SPSS13.0 statistical analysis software, t inspection (inspection level α=0.05) is carried out to related coefficient, P<0.001, the related intimate degree of the surfactant protein value of two kinds of method mensuration is conspicuousnesses, the surfactant protein value that visible two kinds of methods measure is closely related, illustrate that the diagnosis capability of kit is comparatively strong, can clinical practice be promoted.
Claims (1)
1. a surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit, is characterized in that, described kit comprises:
1) Surfactant proteinD calibration object, concentration is 0,2,10,50,200,1000ng/mL;
2) coupling has the nano magnetic microparticle suspending liquid of Streptavidin, and described nano magnetic particulate is the tri-iron tetroxide that surface wraps up with amino or carboxyl-reactive group, particle diameter 10-50nm;
3) biotin labeled Surfactant proteinD antibody, described antibody is monoclonal antibody;
4) Surfactant proteinD abzyme bond, described antibody is polyclonal antibody, and enzyme used is horseradish peroxidase, horseradish peroxidase purity RZ >=3.0, activity >=250U/mL;
5) Surfactant proteinD quality-control product: quality-control product comprises the low value quality-control product of concentration 3ng/mL and the high level quality-control product of 600ng/mL;
6) chemical luminescence for liquid A liquid and B liquid; A liquid is the Tris-HCl damping fluid of 5mmol/L, pH8.6, and containing final concentration 0.7g/L luminol and final concentration 0.165g/L p-iodophenol in this damping fluid; B liquid is 0.675g/L urea peroxide;
7) 20 times of concentrated washing lotions;
8) reaction tube, the material of described reaction tube is transparent polystyrene, transparent polyethylene, transparent polypropylene or clear glass;
It is characterized in that, preparation method comprises the following steps:
(1) preparation of Surfactant proteinD calibration object:
By Surfactant proteinD sterling calibration object diluted to each concentration point be 0,2,10,50,200,1000ng/mL;
Described calibration object dilution is the damping fluid containing 30% cow's serum;
(2) preparation of Surfactant proteinD quality-control product:
With calibration object dilution, Surfactant proteinD sterling is diluted to 3ng/mL and 600ng/mL, 3ng/mL is as low value quality-control product, and 600ng/mL is as high level quality-control product;
(3) preparation of nano magnetic particulate-Streptavidin suspending liquid:
Prepared by A, ferriferrous oxide nano magnetic particle
Adopt the precipitation method to prepare ferriferrous oxide nano magnetic particle, concrete preparation method is as follows: 1) by FeCl
36H
2o and FeCl
24H
2o joins in distilled water with mol ratio 2:1, dissolved with vigorous agitation; 2) add 0.5M ammoniacal liquor under nitrogen atmosphere in above-mentioned iron salt solutions, adjust pH9-10, temperature of reaction 65 DEG C, reaction time 45min; 3), after reaction terminates, be washed with distilled water to neutrality, abandon supernatant, in 60 DEG C of oven dry, obtain the ferriferrous oxide nano magnetic particle of 10-50nm;
The coupling of B, nanometer magnetic bead surface carboxyl groups
Dispersion copolymerization method is adopted to carry out coupling, concrete preparation method is as follows: the nano magnetic microparticulate ultrasound getting above-mentioned preparation is dispersed in 10%PEG8000 solution, obtain magnetic fluid solution, in magnetic fluid solution, 1:10 adds absolute ethyl alcohol by volume, after stirring 30min, moves into stirrer, condenser pipe, in the three-necked bottle of nitrogen inlet, add crosslinking chemical N, N '-methylene-bisacrylamide; Under the protection of nitrogen, be warming up to 60 ± 1 DEG C, constant temperature stirs 30min, add the benzoyl peroxide of magnetic fluid volume 3% afterwards successively, stirring rate is about 500rpm, the styrene of magnetic fluid solution same volume, the acrylic acid of magnetic fluid liquor capacity 25%, keep stream of nitrogen gas, all the other conditions remain unchanged, reaction 8-10h, products therefrom leaves standstill, and uses distilled water cyclic washing, then regulates pH=1 with hydrochloric acid, soak 24h, leave standstill; Use distilled water cyclic washing again, remove not coated Fe
3o
4magnetic, puts into dry 24h at vacuum drying chamber 50 DEG C the product precipitated, obtains the nano magnetic particulate that surface is associated with carboxyl;
The preparation of C, nano magnetic particulate-Streptavidin suspending liquid, preparation 1L, method is as follows:
Get 100mL0.1M MES damping fluid, add the nano magnetic particulate that 10mg surface is associated with carboxyl, stirring at room temperature 40min, add 3.5mg Streptavidin afterwards, then 8mg/mLEDC solution is added, after 2-8 DEG C of reaction 1h, with 0.01M PBS buffer solution 3 times, be finally settled to 1L with 0.01M PBS;
(4) preparation of biotin labeled Surfactant proteinD antibody
Get 0.8mg Surfactant proteinD antibody, to dialyse at 2 ~ 8 DEG C 1 ~ 3h with borate buffer solution; Antibody after dialysis is added 65 μ g biotins, adds dimethyl sulfoxide (DMSO) simultaneously, make dimethyl sulfoxide (DMSO) final mass concentration be greater than 5%, slowly vibrate, lucifuge reaction 2.5h; 250 μ L1M ammonium chloride solutions are added, reacting at normal temperature without light 30-60min in above-mentioned solution; To dialyse at 2 ~ 8 DEG C 24h by 0.01M PBS solution, period changes liquid 2-4 time;
(5) preparation of Surfactant proteinD abzyme bond
After adopting improvement sodium periodate oxidation that Surfactant proteinD antibody and horseradish peroxidase are carried out coupling, be diluted to working concentration 1:4500 with enzyme dilution, and added 11% enzyme stabilizers, be stored in 2 ~ 8 DEG C; Enzyme dilution comprises 10mL/L 2M NaOH, 15g/L NaCl, 10g/LBSA, 5g/L Dextran T-2000,1.05g/L TritonX-100,2.5mL/L gentamicin sulphate, 1mL/L is carmine, and famille rose is powder solid, is mixed with concentration 40mg/mL and uses later, 2g/L Tween-20,1mL/L ProClin300;
The preparation of (6) 20 times of concentrated washing lotions
20 times of concentrated washing lotions comprise 58g/L sodium hydrogen phosphate, 5.92g/L sodium dihydrogen phosphate, 180g/L NaCl, 10mL/LTween-20 and 2%Proclin300;
(7) preparation of chemical luminescence for liquid A liquid and B liquid
A liquid is 0.7g/L luminol, 0.165g/L p-iodophenol, and damping fluid is the 5mmol/L Tris-HCl of pH8.6, keeps in Dark Place; B liquid is 0.675g/L urea peroxide, prepares with process water; The 5min mixing before use of A liquid and B liquid;
(8) assemble: mentioned reagent is assembled into box, is stored in 2 ~ 8 DEG C, each one bottle of often kind of reagent;
(9) to adopting the kit prepared of the method to carry out physical examination, the measured value of linear, precision, the specificity of accuracy, dose-response curve, sensitivity, quality-control product and stability are measured.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310303103.0A CN103364567B (en) | 2013-07-18 | 2013-07-18 | A kind of surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310303103.0A CN103364567B (en) | 2013-07-18 | 2013-07-18 | A kind of surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103364567A CN103364567A (en) | 2013-10-23 |
CN103364567B true CN103364567B (en) | 2015-08-05 |
Family
ID=49366379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310303103.0A Active CN103364567B (en) | 2013-07-18 | 2013-07-18 | A kind of surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103364567B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106970227B (en) * | 2017-05-22 | 2019-02-15 | 上海拜谱生物科技有限公司 | It is a kind of for detecting the quick detection kit and its detection method of estrogen receptor |
CN107192817B (en) * | 2017-05-22 | 2018-04-24 | 广州华弘生物科技有限公司 | A kind of quick detection kit and its detection method for being used to detect PD-L1 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5670328A (en) * | 1992-06-09 | 1997-09-23 | Yamasa Corporation | Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof |
CN101055275A (en) * | 2006-04-13 | 2007-10-17 | 霍夫曼-拉罗奇有限公司 | Means and methods for the differentiation of cardiac and pulmonary causes of shortness of breath |
CN102998467A (en) * | 2012-11-20 | 2013-03-27 | 博奥赛斯(天津)生物科技有限公司 | Quantitative detection kit combining magnetic particles with chemiluminescence immunoassay for beta human chorionic gonadotropin (beta-hCG), and preparation method of kit |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004077056A1 (en) * | 2003-02-27 | 2004-09-10 | Lung Health Diagnostics Pty. Ltd. | A method of diagnosis and agents useful for same |
EP2031397A1 (en) * | 2007-08-30 | 2009-03-04 | F. Hoffmann-La Roche AG | Surfactant proteins B and D in differentiating the causes of shortness of breath |
-
2013
- 2013-07-18 CN CN201310303103.0A patent/CN103364567B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5670328A (en) * | 1992-06-09 | 1997-09-23 | Yamasa Corporation | Monoclonal antibodies to human pulmonary surfactant apoprotein D and use thereof |
CN101055275A (en) * | 2006-04-13 | 2007-10-17 | 霍夫曼-拉罗奇有限公司 | Means and methods for the differentiation of cardiac and pulmonary causes of shortness of breath |
CN102998467A (en) * | 2012-11-20 | 2013-03-27 | 博奥赛斯(天津)生物科技有限公司 | Quantitative detection kit combining magnetic particles with chemiluminescence immunoassay for beta human chorionic gonadotropin (beta-hCG), and preparation method of kit |
Non-Patent Citations (1)
Title |
---|
胡建.Fe3O4/Poly(St-AA)磁性复合高分子微球的制备及生物医学应用.《中国优秀硕士学位论文全文数据库工程科技Ⅰ辑》.2009,(第12期), * |
Also Published As
Publication number | Publication date |
---|---|
CN103364567A (en) | 2013-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103278651B (en) | Kit for chemiluminescence immunity quantitative detection of MYO (myohaemoglobinnano) nano magnetic particle and preparation method of kit | |
CN103364568B (en) | Laminin nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof | |
CN103278623B (en) | A kind of isoenzymes of creatine kinase nano magnetic particulate chemistry electrochemiluminescent immunoassay immue quantitative detection reagent box and preparation method thereof | |
CN102998467B (en) | β human chorionic gonadotrophin magnetic microparticle chemiluminescence immune quantitative detection reagent box and preparation method thereof | |
CN107402308A (en) | Immue quantitative detection reagent boxes of IL 6 and preparation method thereof | |
CN103063851B (en) | Free triiodothyronine nanometer magnetic particle chemiluminescence assay kit and preparation method thereof and detection method thereof | |
CN103293323B (en) | A kind of interstitialcellstimulating hormone (ICSH) nano magnetic particulate chemistry electrochemiluminescent immunoassay immue quantitative detection reagent box and preparation method thereof | |
CN103592445A (en) | Kit for detecting procalcitonin | |
CN103698535B (en) | Platelet-activating factor acetylhydro-lase immue quantitative detection reagent box and preparation, method of operating | |
CN103076455B (en) | Quantitative detection serum amyloid A protein kit and Synthesis and applications thereof | |
CN108445230B (en) | Procalcitonin chemiluminescence detection reagent based on nano antibody and detection method | |
CN102998465B (en) | Quantitative detection kit combining magnetic particles with chemiluminescence immunoassay for angiotensin (Ang) I, and preparation method of kit | |
CN103018445B (en) | CA50 magnetic microparticle chemiluminescence immune quantitative detection reagent box and preparation method thereof | |
CN102998466A (en) | Quantitative detection kit combining magnetic particles with chemiluminescence immunoassay for growth hormone (GH), and preparation method of kit | |
CN108089007A (en) | A kind of kit and preparation method for quantitatively detecting c reactive protein | |
CN104237513A (en) | Thyroid peroxidase antibody magnetic-particle chemiluminescence immune quantitative testing kit | |
CN103558381A (en) | Immunochromatographic test paper for detecting human immunodeficiency virus antibodies and preparation method thereof | |
CN101539576A (en) | Hepatitis B virus pre S1 antigen chemiluminscence immunoassay kit and preparation method thereof | |
CN103063845A (en) | Nanometer magnetic particle chemiluminiscence kit, preparation method and detection method of hepatitis B virus surface-antibody | |
CN108169219A (en) | A kind of kit and preparation method for quantitatively detecting serum amyloid A protein | |
CN103344635B (en) | A kind of Clara cell protein nano-magnetic particle quantitative chemiluminescence immunoassay test kit and preparation method thereof | |
CN103048477B (en) | Nanometer magnetic particle chemiluminescence detection kit for triiodothyronine as well as preparation method and detecting method of same | |
CN103267866B (en) | A kind of FSH nano magnetic particulate chemistry electrochemiluminescent immunoassay immue quantitative detection reagent box and preparation method thereof | |
CN103048476A (en) | Thyroxine nanometer magnetic particle chemiluminiscence determinstion kit as well as preparation method and detection method thereof | |
CN103364567B (en) | A kind of surfactant protein D nano-magnetic particle chemiluminescent immunity quantitative detection kit and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 300300 building 14, international medical device Industrial Park, No. 16, Wujing Road, economic and Technological Development Zone, Dongli District, Tianjin Patentee after: Tianjin boasaisi Biotechnology Co.,Ltd. Address before: 300300 No. 10, Siwei Road, development zone, Dongli District, Tianjin Patentee before: BIOSCIENCE (TIANJIN) DIAGNOSTIC TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address |